Similar to AD, other neurodegenerative diseases such as Parkinson’s are characterized by dysregulated glucose metabolism67 and serum metabolome signatures68—these could potentially be linked to altered GLUT1 expression. This evidence concerns the gene SLC2A1 and Parkinsonism.